Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-19
    E.g., 2018-10-19

Archive Search

1 results
4:07 PM, Nov 02, 2016  |  BC Week In Review | Clinical News  |  Clinical Status

AMC303: Ph I/Ib started

amcure began an open-label, dose-escalation, dose-expansion, European Phase I/Ib trial to evaluate AMC303 in up to …
50 patients. amcure GmbH , Eggenstein-Leopoldshafen, Germany  Product: AMC303   Business: Cancer  Molecular target: Splice variant …